CD8A and neoplasm: RESULTS: The combination of STP and anti-PD-1 synergistically suppressed 4T1 tumor growth, reduced the infiltration of immunosuppressive MDSCs and M2-like tumor-associated macrophages, and reactivated CD8+ T cells.